Jos van Pelt

7.7k total citations
204 papers, 5.7k citations indexed

About

Jos van Pelt is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jos van Pelt has authored 204 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 59 papers in Hepatology and 44 papers in Molecular Biology. Recurrent topics in Jos van Pelt's work include Liver Disease Diagnosis and Treatment (42 papers), Liver Disease and Transplantation (27 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Jos van Pelt is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Liver Disease and Transplantation (27 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Jos van Pelt collaborates with scholars based in Belgium, Netherlands and United States. Jos van Pelt's co-authors include Chris Verslype, Frederik Nevens, David Cassiman, Hannah van Malenstein, Tania Roskams, Tamara Severi, Johan Fevery, Jacques Pirenne, Petra Windmolders and Louis Libbrecht and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jos van Pelt

195 papers receiving 5.6k citations

Peers

Jos van Pelt
Ancha Baranova United States
Hui Shen United States
Je Kyung Seong South Korea
Ancha Baranova United States
Jos van Pelt
Citations per year, relative to Jos van Pelt Jos van Pelt (= 1×) peers Ancha Baranova

Countries citing papers authored by Jos van Pelt

Since Specialization
Citations

This map shows the geographic impact of Jos van Pelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos van Pelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos van Pelt more than expected).

Fields of papers citing papers by Jos van Pelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos van Pelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos van Pelt. The network helps show where Jos van Pelt may publish in the future.

Co-authorship network of co-authors of Jos van Pelt

This figure shows the co-authorship network connecting the top 25 collaborators of Jos van Pelt. A scholar is included among the top collaborators of Jos van Pelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos van Pelt. Jos van Pelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Ricardo A., Chris Verslype, Jos van Pelt, et al.. (2024). Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay. SLAS DISCOVERY. 29(3). 100154–100154.
2.
Fondevila, Flavia, Carolina Méndez‐Blanco, Paula Fernández‐Palanca, et al.. (2021). Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International Journal of Molecular Sciences. 22(21). 11770–11770. 11 indexed citations
3.
Méndez‐Blanco, Carolina, Flavia Fondevila, Paula Fernández‐Palanca, et al.. (2019). Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers. 11(12). 1984–1984. 28 indexed citations
4.
Fevery, Johan, W. Van Steenbergen, Jos van Pelt, et al.. (2016). Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Alimentary Pharmacology & Therapeutics. 43(5). 612–620. 34 indexed citations
5.
Bellassoued, Khaled, et al.. (2015). Protective effect of kombucha on rats fed a hypercholesterolemic diet is mediated by its antioxidant activity. Pharmaceutical Biology. 53(11). 1699–1709. 40 indexed citations
6.
Dekervel, Jeroen, Daphne Hompes, Hannah van Malenstein, et al.. (2014). Hypoxia-Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer Patients. Clinical Cancer Research. 20(8). 2159–2168. 27 indexed citations
7.
Verbeek, Jef, Matthias Lannoo, Eija Pirinen, et al.. (2014). Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut. 64(4). 673–683. 65 indexed citations
8.
Bellassoued, Khaled, Jos van Pelt, & Abdelfattah Elfeki. (2013). Influence of toxic phytoplanktons and heavy metals in the antioxidant response of a common herbivorous fish species (Sarpa salpa). Annals of biological research. 4(3). 152–162. 1 indexed citations
9.
Hamza, Anis, et al.. (2012). Toxicity assessment of dreamfish Sarpa salpa from the Gulf of Gabes (Tunisia, Eastern Mediterranean Sea). Journal of Food Agriculture & Environment. 10(2). 1308–1313. 5 indexed citations
10.
Bellassoued, Khaled, et al.. (2011). Antioxidant response in the salema Sarpa salpa: Interseasonal correlations with the diet. Journal of Food Agriculture & Environment. 9(1). 730–737. 2 indexed citations
11.
Malenstein, Hannah van, Olivier Gevaert, Louis Libbrecht, et al.. (2010). A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma. Clinical Cancer Research. 16(16). 4278–4288. 49 indexed citations
12.
Vekemans, Katrien, Diethard Monbaliu, Hannah van Malenstein, et al.. (2010). Differential Gene Expression Profile in Biomodulated Livers after Transplantation with Cardiac Death Donors. American Journal of Transplantation. 10. 496–496. 1 indexed citations
13.
Vries, Dorottya K. de, J. Lindeman, Dimitrios Tsikas, et al.. (2009). Early Renal Ischemia-Reperfusion Injury in Humans Is Dominated by IL-6 Release from the Allograft. American Journal of Transplantation. 9(7). 1574–1584. 56 indexed citations
14.
Witters, Peter, Marc Hoylaerts, Kathleen Freson, et al.. (2008). Preserved platelet function but plasmatic inhibition of platelets in cholestatic liver disease. Hepatology. 48(4).
15.
Monbaliu, Diethard, Tania Roskams, Johan Fevery, et al.. (2005). Central role of Kupffer cell in ischemic injury following transplantation of non-heart-beating livers. American Journal of Transplantation. 5. 182–182.
16.
Ali, Soegianto, et al.. (2004). TT virus infection in acute and chronic liver diseases and in patients regularly receiving blood products in Belgium.. PubMed. 67(2). 161–5. 11 indexed citations
17.
Verslype, Chris, Frederik Nevens, Geert Maertens, et al.. (2000). Validation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C. Hepatology. 4 indexed citations
18.
Pelt, Jos van, et al.. (1996). [Quality improvement project 'laboratory diagnosis by family physicians' leads to considerable decrease in number of laboratory tests].. PubMed. 140(9). 495–500. 4 indexed citations
19.
Pelt, Jos van, et al.. (1962). Varia. Human Heredity. 12(1). 96–96.
20.
Pelt, Jos van & Joost Huizinga. (1962). Some Observations on the Genetics of Gargoylism. Human Heredity. 12(1). 1–11. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026